Earnings Preview For Atea Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Atea Pharmaceuticals (NASDAQ:AVIR) is set to release its latest quarterly earnings report on August 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.47. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price. The stock is currently trading at $3.47, down 59.96% over the last 52-week period.
August 07, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Atea Pharmaceuticals is expected to report an EPS of $-0.47. Despite beating EPS estimates in the past, the company's share price has typically dropped. The stock is currently down 59.96% over the last 52 weeks.
Atea Pharmaceuticals has a history of beating EPS estimates but this has not translated into a rise in share price. In fact, the share price has typically dropped following the earnings announcement. Given this trend and the fact that the stock is down nearly 60% over the last year, it is likely that the upcoming earnings report could lead to further downward pressure on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100